Skip to main content

Table 5 Outcome of patients

From: Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: a translational study

  Before NICE-SUGAR After NICE-SUGAR P
  n = 82,740 n = 93,765  
ICU LOS (hours, IQR) 39.7 (21.1 to 80.1) 40.8 (21.5 to 84.3) <0.0001
Hospital LOS (days, IQR) 9.7 (5.4 to 18.2) 9.3 (5.3 to 17.8) 0.002
Hospital outcome: home* 68% (56,673) 69% (64,547) 0.12
ICU mortality* 8% (6,480) 7% (6,728) <0.0001
Hospital mortality* 12% (9,989) 11% (10,494) <0.0001
  1. *percentage (number of events); ICU, intensive care unit; LOS, length of stay; NICE-SUGAR, Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation.